Clinical trial
A Randomized Controlled Trial to Investigate the Ideal Sequence of Hybrid Coronary Revascularization with Endoscopic Coronary Revascularization
NCT05184075 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Investigate the Ideal Sequence of Hybrid Coronary Revascularization with Endoscopic Coronary Revascularization
- Lead sponsor
- Jessa Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 9, 2023
- Completion date
- November 9, 2024
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.